News Asymchem Laboratories (Tianjin) Co., Ltd. OTC Markets

Stocks

ASLT.Y

US04651E1038

Pharmaceuticals

All News

Mentions Relevance

08-24	Asymchem Laboratories' H1 Profit Declines 16%	MT
08-24	Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-31	Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6%	MT
07-29	Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor	CI
07-27	AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building	CI
07-10	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy	MT
07-10	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy	MT
06-11	Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026	CI
05-27	AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates	GL
05-27	AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates	AQ
05-27	Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates	CI
05-20	Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says	RE
05-15	Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026	CI
05-13	Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says	RE
05-04	JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows	RE
04-28	Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8%	MT
04-27	Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-27	Asymchem Laboratories (Tianjin) Q1 net profit down 6.8% Y/Y	RE
04-21	Asymchem Laboratories Profit Rises 19% in 2025	MT
04-14	Asymchem Unveils Fully Integrated TIDES Commercial Supply Matrix	CI
04-01	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$115.43 From HK$114.68, Keeps at Buy	MT
04-01	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 132.37 Yuan From 131.51 Yuan, Keeps at Buy	MT
03-30	Asymchem Laboratories (Tianjin) 2025 net profit up 19.4% Y/Y	RE
03-30	Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-29	Asymchem Laboratories Co., Ltd. announces Annual dividend, payable on June 26, 2026	CI